Cleveland Clinic Taussig Cancer Center Investigational Pharmacy is a clinical research site located in Cleveland, Ohio, United States 44106.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Cleveland Clinic Taussig Cancer Center Investigational Pharmacy has participated in 8 clinical trials with 5 currently active.
Therapeutic areas: Advanced Solid Tumors, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Neoplasms.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Cleveland Clinic Taussig Cancer Center Investigational Pharmacy has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cleveland Clinic Taussig Cancer Center Investigational Pharmacy has 8 clinical trials on record, with 5 currently active. Their work covers Advanced Solid Tumors, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Neoplasms.
Yes — Cleveland Clinic Taussig Cancer Center Investigational Pharmacy holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.